OpenAlex
PricingAboutJobs
Log inGet started
Work

Double-Blind, Controlled Phase II Study of a 5-HT6 Receptor Antagonist, SB-742457, in Alzheimers Disease

HTML

Year: 2010
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Current Alzheimer Research
DOI: 10.2174/156720510791383831
Authors: G. Maher-Edwards, M. Zvartau-Hind, A.J. Hunter, M. Gold, G. Hopton, G. Jacobs, M. Davy, P. Williams
Institution: GlaxoSmithKline (United Kingdom)
Language: English

Topic: Alzheimer's disease research and treatments
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: 5-HT6 receptor antagonists, Alzheimer's disease, mild to moderate dementia, cognitive impairment, dose-response relationship, ADAS-Cog, tolerability, adverse events, model-based design
SDG: Good health and well-being

Open Access status: closed

Funder: National Institute of Neurological Disorders and Stroke
OpenAlex ID: W2121476689
FWCI: 3.751
Cites:
Cited by: 120
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security